UPDATED Jul 25, 2024
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
NOW | US$828.79 | 13.4% | 48.0% | US$150.5b | US$870.00 | PE148.9x | E22.0% | n/a | Software | ||
TSLA | US$220.25 | 2.0% | -13.9% | US$690.0b | US$203.74 | PE56.8x | E17.3% | n/a | Automobiles | ||
RTX | US$113.47 | 8.2% | 33.2% | US$139.1b | US$107.87 | PE43.3x | E17.2% | 2.2% | Capital Goods | ||
ABBV | US$182.17 | 3.4% | 22.4% | US$311.2b | US$185.62 | PE54.1x | E23.4% | 3.4% | Pharmaceuticals & Biotech | ||
XOM | US$117.43 | 2.1% | 11.4% | US$453.4b | US$132.96 | PE14.1x | E5.9% | 3.2% | Energy | ||
JNJ | US$159.64 | 2.2% | -8.1% | US$376.1b | US$170.67 | PE23.5x | E6.9% | 3.1% | Pharmaceuticals & Biotech | ||
TMO | US$594.50 | 3.4% | 6.2% | US$219.4b | US$631.52 | PE36.5x | E10.4% | 0.3% | Pharmaceuticals & Biotech | ||
IBM | US$191.98 | 4.3% | 34.3% | US$169.0b | US$184.09 | PE21x | E4.8% | 3.5% | Software | ||
CRM | US$256.52 | 2.7% | 13.9% | US$242.0b | US$300.19 | PE45.4x | E13.7% | 0.6% | Software | ||
CVX | US$157.54 | 1.6% | -1.3% | US$285.8b | US$181.81 | PE14.3x | E4.5% | 4.1% | Energy | ||
NOC | US$470.57 | 6.4% | 5.7% | US$65.4b | US$501.66 | PE32.3x | E13.9% | 1.8% | Capital Goods | ||
CAT | US$344.30 | 2.5% | 33.3% | US$164.3b | US$347.49 | PE15x | E-2.1% | 1.5% | Capital Goods | ||
SCHW | US$66.24 | 3.4% | 0.6% | US$117.1b | US$75.45 | PE27.5x | E17.8% | 1.5% | Diversified Financials | ||
PEP | US$171.02 | 1.7% | -9.3% | US$231.0b | US$182.17 | PE24.7x | E9.0% | 3.2% | Food, Beverage & Tobacco | ||
GILD | US$76.51 | 4.1% | 0% | US$91.6b | US$82.47 | PE196.5x | E37.1% | 4.0% | Pharmaceuticals & Biotech | ||
DE | US$381.69 | 3.3% | -10.9% | US$101.8b | US$418.27 | PE11.1x | E-8.2% | 1.5% | Capital Goods | ||
DHR | US$270.09 | 1.6% | 5.8% | US$191.9b | US$285.42 | PE48.1x | E14.4% | 0.4% | Pharmaceuticals & Biotech | ||
HD | US$353.29 | 0.9% | 7.2% | US$347.4b | US$383.14 | PE23.6x | E5.3% | 2.5% | Retail | ||
BX | US$140.02 | 1.7% | 35.6% | US$168.4b | US$134.11 | PE53.9x | E26.1% | 2.4% | Diversified Financials | ||
TEAM | US$178.22 | 6.3% | 4.5% | US$43.6b | US$238.30 | PS11.1x | E45.7% | n/a | Software | ||
CBRE | US$107.43 | 9.3% | 29.0% | US$29.6b | US$105.00 | PE32.6x | E16.8% | n/a | Real Estate Management and Development | ||
PM | US$113.20 | 1.6% | 14.8% | US$173.2b | US$115.70 | PE20x | E9.5% | 4.6% | Food, Beverage & Tobacco | ||
FCNC.A | US$2,051.05 | 10.1% | 44.4% | US$26.9b | US$2,025.83 | PB1.4x | E-1.5% | 0.3% | Banks | ||
SHW | US$342.74 | 3.2% | 23.7% | US$83.8b | US$357.82 | PE34.4x | E8.0% | 0.8% | Materials |